|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-04
|
$2,507,598
|
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
$30,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
$3,750
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
X-ray/Fluorescence Molecular and Diffuse Optical Tomography of Glioma
|
5K25CA138578-04
|
$186,392
|
$186,392
|
Leblond, Frederic
|
DARTMOUTH COLLEGE
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
5K08CA218460-02
|
$106,531
|
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
$179,121
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
$8,999
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
$17,962
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$5,104
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$14,033
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$16,380
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$180,180
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Web-based Physical Activity Intervention for Children with ALL
|
5R01CA193478-03
|
$826,706
|
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-03
|
$2,300,000
|
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Washington University Human Tumor Atlas Research Center
|
1U2CCA233303-01
|
$1,752,191
|
$578,223
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
VU PREDICT
|
1U24CA220325-01A1
|
$664,613
|
|
MANNING, HENRY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
7R00CA207848-04
|
$165,808
|
|
WARREN ANDERSEN, SHANEDA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
4R00CA207848-03
|
$19,074
|
|
WARREN ANDERSEN, SHANEDA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-28
|
$607,994
|
$6,080
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-03
|
$176,941
|
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
VHL
|
ZIA CP005803 08290
|
$52,954
|
$15,886
|
Caporaso, Neil
|
DCEG (NCI)
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-03S2
|
$65,611
|
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-22S1
|
$139,963
|
$1,400
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-22
|
$399,112
|
$3,991
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S1
|
$218,356
|
$2,184
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S2
|
$203,848
|
$2,038
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S3
|
$86,197
|
$862
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
$21,700
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular targeted pan PI-3 kinase inhibitor prodrug, SF1126 for glioma therapy
|
5R01CA094233-09
|
$268,308
|
$268,308
|
DURDEN, DONALD
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-19
|
$961,183
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of PROMIS Measures in Children with Brain Tumors
|
1R01CA174452-01
|
$331,803
|
$331,803
|
LAI, JIN-SHEI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Validation of microRNA Targets in Glioma
|
5R01CA138734-03
|
$351,692
|
$351,692
|
Krichevsky, Anna
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Validation of a novel, adjuvant implant for post-metastatic skeletal lesions
|
1R43CA221553-01A1
|
$299,958
|
|
MARGULIES, BRYAN
|
FUSOLOGICS, LLC
|
|
Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
|
1R21CA218973-01A1
|
$203,042
|
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
1P01CA154291-01A1
|
$1,651,535
|
$1,304,713
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
$91,114
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
$1,497
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
$2,800
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing proteoglycan biology to develop a novel treatment for brain cancers
|
1F31CA168198-01
|
$31,217
|
$31,217
|
Raman, Karthik
|
UNIVERSITY OF UTAH
|
|
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
|
1R01CA229259-01
|
$247,340
|
|
LIEU, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
Total relevant funding to Brain for this search: $230,792,592
|